• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses

tetano

Editor, Senior Moderator
Cell Rep


. 2024 Aug 27;43(9):114645.
doi: 10.1016/j.celrep.2024.114645. Online ahead of print. Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses

Ida Paciello[SUP] 1 [/SUP], Giulio Pierleoni[SUP] 2 [/SUP], Elisa Pantano[SUP] 2 [/SUP], Giada Antonelli[SUP] 1 [/SUP], Piero Pileri[SUP] 1 [/SUP], Giuseppe Maccari[SUP] 3 [/SUP], Dario Cardamone[SUP] 3 [/SUP], Giulia Realini[SUP] 1 [/SUP], Federica Perrone[SUP] 2 [/SUP], Martin Mayora Neto[SUP] 4 [/SUP], Simone Pozzessere[SUP] 5 [/SUP], Massimiliano Fabbiani[SUP] 6 [/SUP], Francesca Panza[SUP] 7 [/SUP], Ilaria Rancan[SUP] 7 [/SUP], Mario Tumbarello[SUP] 6 [/SUP], Francesca Montagnani[SUP] 6 [/SUP], Duccio Medini[SUP] 3 [/SUP], Piet Maes[SUP] 8 [/SUP], Nigel Temperton[SUP] 4 [/SUP], Etienne Simon-Loriere[SUP] 9 [/SUP], Olivier Schwartz[SUP] 10 [/SUP], Rino Rappuoli[SUP] 11 [/SUP], Emanuele Andreano[SUP] 12 [/SUP]



Affiliations
Abstract

Understanding the evolution of the B cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is fundamental to design the next generation of vaccines and therapeutics. We longitudinally analyze at the single-cell level almost 900 neutralizing human monoclonal antibodies (nAbs) isolated from vaccinated people and from individuals with hybrid and super hybrid immunity (SH), developed after three mRNA vaccine doses and two breakthrough infections. The most potent neutralization and Fc functions against highly mutated variants belong to the SH cohort. Repertoire analysis shows that the original Wuhan antigenic sin drives the convergent expansion of the same B cell germlines in vaccinated and SH cohorts. Only Omicron breakthrough infections expand previously unseen germ lines and generate broadly nAbs by restoring IGHV3-53/3-66 germ lines. Our analyses find that B cells initially expanded by the original antigenic sin continue to play a fundamental role in the evolution of the immune response toward an evolving virus.

Keywords: B cell germlines; COVID-19; CP: Immunology; Fc functions; SARS-CoV-2; V(D)J genes; antigenic sin; breakthrough infection; memory B cells; neutralizing antibodies.

 
Back
Top Bottom